Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2011-03-01
2011-03-01
McGarry, Sean R (Department: 1635)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C435S006120, C435S375000, C435S377000, C536S023100, C536S024100, C536S024500
Reexamination Certificate
active
07897582
ABSTRACT:
Compositions and methods for the treatment of asthma with oligonucleotides which specifically hybridize with nucleic acids encoding B7 proteins.
REFERENCES:
patent: 4689320 (1987-08-01), Kaji
patent: 4806463 (1989-02-01), Goodchild et al.
patent: 5004810 (1991-04-01), Draper
patent: 5034506 (1991-07-01), Summerton et al.
patent: 5087617 (1992-02-01), Smith
patent: 5098890 (1992-03-01), Gewirtz et al.
patent: 5135917 (1992-08-01), Burch
patent: 5138045 (1992-08-01), Cook et al.
patent: 5166195 (1992-11-01), Ecker
patent: 5194428 (1993-03-01), Agrawal et al.
patent: 5218105 (1993-06-01), Cook et al.
patent: 5242906 (1993-09-01), Pagano et al.
patent: 5264423 (1993-11-01), Cohen et al.
patent: 5276019 (1994-01-01), Cohen et al.
patent: 5286717 (1994-02-01), Cohen et al.
patent: 5434131 (1995-07-01), Linsley et al.
patent: 5459255 (1995-10-01), Cook et al.
patent: 5512438 (1996-04-01), Ecker
patent: 5514788 (1996-05-01), Bennett et al.
patent: 5539082 (1996-07-01), Nielsen et al.
patent: 5667998 (1997-09-01), Dougherty et al.
patent: 5801154 (1998-09-01), Baracchini et al.
patent: 5877021 (1999-03-01), Stinchcomb et al.
patent: 5883082 (1999-03-01), Bennett et al.
patent: 5942607 (1999-08-01), Freeman et al.
patent: 5998148 (1999-12-01), Bennett et al.
patent: 6077833 (2000-06-01), Bennett et al.
patent: 6319906 (2001-11-01), Bennett et al.
patent: 6582908 (2003-06-01), Fodor et al.
patent: 7115580 (2006-10-01), Bennett et al.
patent: 2001/0053519 (2001-12-01), Fodor et al.
patent: 2003/0228597 (2003-12-01), Cowsert et al.
patent: 0600591 (1993-10-01), None
patent: 0643077 (1994-09-01), None
patent: WO 92/20823 (1992-11-01), None
patent: WO 93/24134 (1993-12-01), None
patent: WO 94/17773 (1994-08-01), None
patent: WO 95/03408 (1995-02-01), None
patent: WO 95/05464 (1995-02-01), None
patent: WO 95/06738 (1995-03-01), None
patent: WO 95/07358 (1995-03-01), None
patent: WO 95/22619 (1995-08-01), None
patent: WO 95/32734 (1995-12-01), None
patent: WO 95/34320 (1995-12-01), None
patent: WO 96/11279 (1996-04-01), None
patent: WO 96/15780 (1996-05-01), None
patent: WO 96/18736 (1996-06-01), None
patent: WO 99/01579 (1999-01-01), None
patent: WO 00/74687 (2000-12-01), None
patent: WO 03/083089 (2003-10-01), None
Bennett et al Biochimica et Biophysica ACAT vol. 1489:19-30, 1999.
Alberts et al., “Molecular Biology of the Cell” Garland Publishing Inc. (1983) New York, 411-415.
Allison et al., “The Yin and Yang of T Cell Costimulation” Science (1995) 270:932-933.
Allison, “CD28-B7 interactions in T-cell activation” Curr. Opin. Immunol. (1994) 6:414.
Azuma et al., “B70 antigen is a second ligand for CTLA-4 and CD28” Nature (1993) 366:76-79.
Berkow et al., “The Merck Manual of Diagnosis and Therapy” 15th ed. (1987) Rahway, NJ, 302-336 and 2516-2522.
Borriello et al., “Characterization of the Murine B7-1 Genomic Locus Reveals an Additional Exon Encoding an Alternative Cytoplasmic Domain and a Chromosomal Location of Chromosome 16, Band 15” J. Immunol. (1994) 153:5038.
Borriello et al., “Differential Expression of Alternate mB7-2 Transcripts” J. Immunol. (1995) 155:5490-5497.
Brand et al., “Transdermal delivery of antisense compounds” Advanced Drug Delivery Review (2000) 44:51-57.
Brigstock et al., “Species-Specific High Molecular Weight Forms of Basic Fibroblast Growth Factors” Growth Factors (1990) 4:45-52.
Charachon et al., “Phosphorothioate Analogues of (2′-5′) (A)4: Agonist and Antagonist Activities in Intact Cells” Biochemistry (1990) 29:2550-2555.
Chen et al., “Monoclonal Antibody 2D10 Recognizes a Novel T Cell Costimulatory Molecule on Activated Murine B Lymphocytes” J. Immunol. (1994) 152:2105-2114.
Chen et al., “Molecular Cloning and Expression of Early T Cell Costimulatory Molecule-1 and its Characterization as a B7-2 Molecule” J. Immunol. (1994) 152:4929-4936.
Cook, “Medicinal Chemistry Strategies for Antisense Research” Antisense Research Applications (1993) CRC Press, Boca Raton, 171-172.
Crooke et al., “Antisense Research and Applications” CRC Press, Boca Raton (1993) 171-172.
Crooke et al., “Pharmokinetic Properties of Several Novel Oligonucleotide Analogs in mice” J. Pharmacol. Exp. Ther. (1996) 227:923-937.
Database WPI, Section Ch, Week 199804, XP002230059, Derwent Publications Ltd. (1997).
De Virgilio et al., “Cloning and Disruption of a Gene Required for Growth on Acetate but not on Ethanol: the Acetyl-Coenzyme a Synthetase Gene ofSaccharomyces cerevisiae” Yeast (1992) 8:1043-1051.
Dulbecco et al., “Plaque Production by the Polyoma Virus” Virol. (1959) 8:396-397.
European Search Report for Application # 97953268.6 dated Dec. 10, 2001.
European Search Report for Application # 00939350.5 dated Mar. 13, 2003.
European Search Report for Application # 04752823.7 dated Apr. 17, 2008.
Freeman et al., “Structure, Expression, and T Cell Costimulatory Activity of the Murine Homologue of the Human B Lymphocyte Activation Antigen B7” J. Exp. Med. (1991) 174:625-631.
Freeman et al., “B7, A New Member of the Ig Superfamily with Unique Expression on Activated and Neoplastic B Cells” J. Immunol. (1989) 143:2714-2722.
Freeman et al., “Cloning of B7-2: A CTLA-4 Counter Receptor That Costimulates Human % Cell Proliferation” Science (1993) 262:909-911.
French et al., “Expression of Two Related Nonstructural Proteins of Bluetongue Virust (BTV) Type 10 in Insect Cells by a Recombinant Baculovirus: Production of Polyclonal Ascitic Fluid and Characterization of the Gene Product in BTV-Infected BHK Cells” J. Virol. (1989) 63:3270-3278.
Gao et al., “Cloning and Characterization of a Mouse Gene with Homology to the Human von Hippel-Lindau Disease Tumor Suppressor Gene: Implications for the Potential Organization of the Human von Hippel-Lindau Disease Gene” Cancer Res. (1995) 55:743-747.
Gebeyehu et al., “Novel biotinylated nucleotide—analogs for labeling and colorimetric detection of DNA” Nucleic Acids Res. (1987) 15:4513-4534.
Gelbert et al., “Analysis of GPT Activity in Mammalian Cells with a Chromosomally Integrated Shuttle Vector Containing Altered gpt Genes” Somat. Cell. Mol. Genet. (1990) 16:173-184.
Gold et al., “Escherichia coliandSalmonella typhimurium: Cellular and Molecular Biology” vol. 2, 1987.
Hakim et al., “Acute Graft-Versus-Host Reaction Can be Aborted by Blockade of Costimulatory Molecules” J. Immun. (1995) 155:1760-1766.
Harlan et al., “Mice expressing both B7-1 and viral glycoprotein on pancreatic beta cells along with glycoprotein-specific transgenic T Cells develop diabetes due to a breakdown of T-lymphocyte unresponsiveness” PNAS (1994) 91:3137-3141.
Hathcock et al., “Identification of an Alternative CTLA-4 Ligand Costimulatory for T Cell Activation” Science (1993) 262:905-907.
Inobe et al., “The Role of the B7-1a Molecule, an Alternatively Spliced Form of Murine B7-1 (CD80), on T Cell activation” J. Immun. (1996) 157:582-588.
International Search Report for Application # PCT/US97/23270 dated Mar. 26, 1998.
International Search Report for Application # PCT/US00/14471 dated Aug. 14, 2000.
International Search Report for Application # PCT/US2004/015880 dated Nov. 22, 2005.
Jellis et al., “Genomic Organization of the gene coding for the costimulatory human B-lymphocyte antigen (CD86)” Immunogenet. (1995) 42:85.
June et al., “The B7 and CD28 receptor families” Immunol. Today (1994) 15:321-331.
Kabanov et al., “A new class of antivirals: antisense oligonucleotides combined with a hydrophobic substituent effectively inhibit influenza virus reproduction and synthesis of virus-specific proteins in MDCK cells” FEBS Lett. (1990) 259:327-330.
Kanagasundaram et al., “Isolation and characterization of the gene encoding gluco
Bennett C. Frank
Freier Susan M
ISIS Pharmaceuticals Inc.
Knobbe Martens Olson & Bear
McGarry Sean R
LandOfFree
Oligonucleotide compositions and methods for the modulation... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oligonucleotide compositions and methods for the modulation..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oligonucleotide compositions and methods for the modulation... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2658096